Fatal toxic epidermal necrolysis in autoimmune polyglandular syndrome Type I

Journal of Endocrinological Investigation

Volumn 27, Issue 5, 2004, Pages 475-479

  Porzionato, A ^a   Zancaner, S ^a   Betterle, C ^a   Ferrara, S D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Addison's disease; Autoimmune polyglandular syndrome; Corticosteroid; Hypoparathyroidism; Toxic epidermal necrolysis

Indexed keywords

ALUMINUM; AMOXICILLIN PLUS CLAVULANIC ACID; BETAMETHASONE; CALCITRIOL; CALCIUM CARBONATE; CALCIUM LACTOGLUCONATE; CANRENOIC ACID; CEFACLOR; CORTISONE ACETATE; DIAZEPAM; FLUDROCORTISONE; FUROSEMIDE; GENTAMICIN; GLUCONATE CALCIUM; HALOPERIDOL; HYDROCORTISONE SODIUM SUCCINATE; ITRACONAZOLE; LEVOFLOXACIN; MAGNESIUM; METOCLOPRAMIDE; NYSTATIN; OMEPRAZOLE; PANTOPRAZOLE; PIPERACILLIN; POTASSIUM CHLORIDE; POVIDONE IODINE; RABEPRAZOLE; RANITIDINE; RIFAMYCIN; UNINDEXED DRUG;

ADDISON DISEASE; ADULT; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BRONCHOPNEUMONIA; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTITIS; FEMALE; HALLUCINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; HYPOKALEMIA; HYPOPARATHYROIDISM; KIDNEY DISEASE; MENTAL DISEASE; MUCOCUTANEOUS CANDIDIASIS; STOMACH DISEASE; THRUSH; TOXIC EPIDERMAL NECROLYSIS;

EID: 3242695096     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345295     Document Type: Article

References (28)

1. Mignogna MD, Fedele S, Lo Russo L, Ruoppo E, Lo Muzio L. Polyglandular autoimmune syndrome Type II associated with oral lichen planus. Int J Dermatol 2002, 41: 244-6.
2. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002, 23: 327-64.
3. Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome Type 1. J Clin Endocrinol Metab 1998, 83: 1049-55.
4. Neufeld M, MacLaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine 1981, 60: 355-62.
5. Chen S, Sawicka J, Betterle C, et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 1996, 81: 1871-6.
6. Meyer G, Badenhoop K. Autoimmune regulator (AIRE) gene on chromosome 21: implications for autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) any more common manifestations of endocrine autoimmunity. J Endocrinol Invest 2002, 25: 804-11.
7. Carboni I, Soda R, Bianchi L, Chimenti S. Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expression of autoimmune polyglandular syndrome Type I. Acta Dermatol Venereol 2002, 82: 68-9.
8. Oblinger E, Cibis A, Peter RU, Proebstle TM. Anogenital condylomata acuminata, mucocutaneous candidiasis, vitiligo, keratopathy and primary hypoparathyroidism in an autoimmune polyglandular syndrome Type 1. Dtsch Med Wochenschr 1997, 122: 1382-6.
9. Sporkmann KH, Eickhoff R, Dominik HC. Subsepsis allergica in a patient with Type I polyglandular autoimmune syndrome. Monatsschr Kinderheilkd 1990, 138: 619-22.
10. Kappeler D, Troendle A, Mueller B. Localized granuloma annulare associated with autoimmune thyroid disease in a patient with a positive family history for autoimmune polyglandular syndrome Type II. Eur J Endocrinol 2001, 145: 101-2.
11. Papadopoulos KI, Hornbald Y, Liljebladh H, Hallengren B. High frequency of endocrine autoimmunity in patients with sarcoidosis. Eur J Endocrinol 1996, 134: 331-6.
12. Franzese A, Valerio G, Di Maio S, Iannucci MP, Bloise A, Tenore A. Growth hormone insufficiency in a girl with the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Endocrinol Invest 1999, 22: 66-9.
13. Wilson PW, Buckley CE, Eisenbarth GS. Disordered immune function in patients with polyglandular failure. J Clin Endocrinol Metab 1981, 52: 284-8.
14. Peterson P, Perheentupa J, Krohn KJ. Detection of candidal antigens in autoimmune polyglandular syndrome Type I. Clin Diagn Lab Immunol 1996, 3: 290-4.
15. Betterle C, Mirakian R, Doniach D, Bottazzo GF, Riley W, MacLaren N. Antibodies to melanocytes in vitiligo. Lancet 1984, 1: 159.
16. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. New Engl J Med 1994, 331: 1272-85.
17. Rappersberger K, Foedinger D. Treatment of erythema multiforme, Stevens-Johnson Syndrome, and toxic epidermal necrolysis. Dermatol Ther 2002, 15: 397-408.
18. Kelly JP, Auquier A, Rzany B, et al. An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol 1995, 48: 1099-108.
19. Palmieri TL, Greenhalgh DG, Saffle JR, et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002, 23: 87-96.
20. Strom BL, Carson JL, Halpern AC, et al. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 1991, 127: 831-8.
21. McCormack JG. Mycoplasma pneumoniae and the erythema multiforme Stevens-Johnson syndrome. J Infect 1981, 3: 32-6.
22. Roujeau JC, Chosidow O, Saiag P, Guillaume JC. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990, 23: 1039-58.
23. Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987, 123: 1171-3.
24. Burge SM, Dawber RPR. Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus. J Am Acad Dermatol 1985, 13: 665-6.
25. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. New Engl J Med 1993, 328: 1670-4.
26. Solinas A, Cottoni F, Tanda F, Tocco A. Toxic epidermal necrolysis in a patient affected by mixed essential cryoglobulinemia. J Am Acad Dermatol 1988, 18: 1165-9.
27. Rzany B, Schmitt H, Schopf E. Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Dermatol Venereol 1991, 71: 171-2.
28. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and risk of Stevens-Johnson syndrome ortoxic epidermal necrolysis. New Engl J Med 1995, 333: 1600-07.